Indivior Announces FY and Q4 2024 Financial Results

Rhea-AI Summary

Indivior PLC (Nasdaq/LSE: INDV) has announced its financial results for the fiscal year and fourth quarter of 2024, ending December 31, 2024. The company will host a live webcast presentation at 13:00 BST (8:00 am ET), led by CEO Mark Crossley.

The earnings release and investor presentation materials are available on the company's website at www.indivior.com. Participants can join the presentation through a webcast link or register for telephonic access.

News Market Reaction

-17.60%

1 alert

-17.60% News Effect

On the day this news was published, INDV declined 17.60%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SLOUGH, United Kingdom and RICHMOND, Va., Feb. 20, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending December 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com.

• The earnings release can be found at www.indivior.com/investors
• The investor presentation can be found at www.indivior.com/investors (at 7:00 am ET)

There will be a live webcast presentation at 13:00 BST (8:00 am ET) hosted by Mark Crossley, CEO. The details are below.

Webcast link: https://edge.media-server.com/mmc/p/bfut8veu
Participants may access the presentation telephonically by registering with the following link:
https://register.vevent.com/register/BIb27314d7848f43e682309a38029a2114
(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration) 

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD). Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-announces-fy-and-q4-2024-financial-results-302379345.html

SOURCE Indivior PLC

FAQ

When will Indivior (INDV) release its Q4 2024 earnings presentation?

Indivior's Q4 2024 earnings presentation is scheduled for February 20, 2025, at 13:00 BST (8:00 am ET).

How can investors access Indivior's (INDV) Q4 2024 earnings call?

Investors can access the earnings call either through a webcast link or by registering for telephonic access through the provided registration link.

Where can I find Indivior's (INDV) Q4 2024 earnings release and investor presentation?

The earnings release and investor presentation are available on Indivior's website at www.indivior.com/investors.

Who will host Indivior's (INDV) Q4 2024 earnings presentation?

The earnings presentation will be hosted by Mark Crossley, CEO of Indivior.